ProLingua RX: Language communication tool for pharmacists (Phase II)

ProLingua RX：药剂师语言交流工具（第二阶段）

• 批准号: 7220093
• 负责人: Chung-Suk Charles Lee
• 金额: $ 39.19万
• 依托单位: POLYGLOT SYSTEMS, INC.
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-09-01 至 2009-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7220093
• 关键词: Accounting; Applications Grants; Budgets; Cessation of life; Communication Tools; Computers; Daily; Data Set; Databases; Development; English Language; Goals; Home environment; Injury; Institute of Medicine (U.S.); Institution; Instruction; Internet; Koreans; Language; Letters; Link; Medication Errors; Medicine; Methods; Online Systems; Patients; Pharmaceutical Preparations; Pharmacists; Pharmacy Schools; Pharmacy facility; Phase; Population; Progress Reports; Sales; Schedule; Small Business Funding Mechanisms; Small Business Innovation Research Grant; Solutions; System; Techniques; Technology; Time; Translating; Translations; United States; Visual; Writing; base; concept; cost; foreign language; health care delivery; health disparity; health literacy; innovation; prescription document; prescription procedure; prototype; response

DESCRIPTION (provided by applicant): ProLingua RX: Language communication tool for pharmacists. Twenty million people in the United States are unable to speak an effective level of the English language to understand simple medicine instructions. This Limited English Proficient (LEP) population represents 1 of every 15 people in the United States. This population is expected to increase 40% over the next 20 years. The Institute of Medicine (IOM) estimates that medication errors account for about 7,000 deaths annually and costs approximately $2 billion for the nation as a whole. Medication errors were also found to account for over 700,000 injuries each year. Language barrier has been found to be a significant cause of some of these deaths and injuries. During Phase I we developed an innovative system for professional pharmacists to generate medicine instructions in a foreign language, provide these instructions to LEP patients in both written and verbal form, and demonstrate proper techniques for medication use. During Phase II we will expand upon this system by incorporating 6 foreign languages (Spanish, Korean, Mandarin, Russian, Vietnamese, and Arabic), adding the top 300 prescriptions to our medicine database, creating 50 new medicine demonstrations, and developing a system to enable access to these instructions from any remote computer through the Internet. The goal of this Phase II grant application is to develop a commercial, technology-based, time-saving solution to help every pharmacist articulate and visually demonstrate medications instructions to their patients regardless of language barrier. This solution has the potential to significantly reduce medication errors and health disparity due to language barriers as well as low health literacy, while reducing cost of healthcare delivery in the United States.

描述（申请人提供）：Prolingua rx：药剂师的语言通信工具。在美国，两千万人无法说出有效的英语水平来了解简单的医学指示。这个有限的英语熟练（LEP）人口代表美国每15人中的1人。预计在未来20年中，该人口将增加40％。医学研究所（IOM）估计，药物错误每年约为7,000人死亡，整个国家的损失约为20亿美元。还发现药物错误每年造成超过70万伤害。已经发现语言障碍是其中一些死亡和伤害的重要原因。在第一阶段，我们为专业药剂师开发了一种创新的系统，以用外语生成医学说明，以书面形式和口头形式为LEP患者提供这些说明，并展示了适当的药物使用技术。在第二阶段期间，我们将通过纳入6种外语（西班牙，韩语，普通话，俄罗斯，越南语和阿拉伯语）来扩展该系统，并在我们的医学数据库中添加了前300个处方，创建了50种新的医学演示，并开发了一个系统，可以通过Internet从任何远程计算机中访问这些指令。该第二阶段赠款应用的目的是开发一种基于技术的，节省时间的解决方案，以帮助每个药剂师表达并视觉上向患者展示药物指示，而不论语言障碍如何。该解决方案有可能显着减少由于语言障碍和低健康素养而导致的药物错误和健康差异，同时降低美国医疗保健的成本。